First Line Treatment of Meniere’s Disease: A Randomized Controlled Trial

Authors

  • Anup Acharya Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa
  • Madan Mohan Singh Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa
  • Arati Shrestha Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa

Keywords:

Betahistine, Dietary sodium chloride, Diuretics, Meniere disease, Randomized controlled trial

Abstract

Introduction: There is no consensus on the first line medical treatment of Meniere disease to produce symptomatic improvement and slow the disease progress. Dietary salt restriction, diuretics, and vasodilators like betahistine are among the first line drugs that have been used for long. There is lack of evidence due to paucity of quality studies to support their effectiveness and advocate their use. This study is done to evaluate the effectiveness of three first line treatment of Meniere disease i.e. salt restriction, oral diuretics, and betahistine.

Methods: Double blind randomized controlled trial was carried out in out-patient clinic of Ear Nose and Throat department of Lumbini Medical College Teaching Hospital.  Cases  were  randomized  into  three  groups;  dietary  salt  restriction,  diuretics  as  amiloride  and furosemide, and vasodilator as betahistine. Pre and post treatment evaluation was done in terms of number and severity of vertigo, tinnitus, and hearing outcome.

Results: There were a total of 97 cases with F:M ratio of 1.1:1. Mean age of patients was 47.86 yr (SD=12.7). Twenty-nine (30%) were treated with dietary sodium restriction alone (Group A), 35 (36%) were treated with diuretics (Group B) and the rest 33 (34%) were treated with vasodilator (betahistine, Group C). There was no significant difference in hearing outcome in any group. Tinnitus was significantly improved in Group B. Number of vertigo attack was significantly decreased in Group B and Group C. Severity of vertigo was significantly decreased in Group B.

Conclusion: Dietary salt restriction alone was not effective in controlling any aspect of the disease whereas diuretics were effective in reducing tinnitus and number and severity of vertigo. Betahistine was effective in reducing the number of vertigo attacks but not effective on other aspects of the disease.

J. Lumbini. Med. Coll.Vol 4, No 2, July-Dec 2016, page: 68-71

DOI: https://doi.org/10.22502/jlmc.v4i2.93

Downloads

Download data is not yet available.
Abstract
2585
PDF
1687

Author Biographies

Anup Acharya, Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa

Assistant Professor

Madan Mohan Singh, Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa

Associate Professor

Arati Shrestha, Department of Ear Nose Throat, Head and Neck Surgery Lumbini Medical College, Palpa

Medical Officer

Downloads

Published

2017-01-26

How to Cite

Acharya, A., Singh, M. M., & Shrestha, A. (2017). First Line Treatment of Meniere’s Disease: A Randomized Controlled Trial. Journal of Lumbini Medical College, 4(2), 68–71. Retrieved from https://nepjol.info./index.php/JLMC/article/view/16465

Issue

Vol. 4 No. 2 (2016)

Section

Original Research Articles

License

The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution(CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

JLMC requires an exclusive licence allowing to publish the article in print and online.

The corresponding author should read and agree to the following statement before submission of the manuscript for publication,

License agreement
In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:

  1. I am authorized by my co-authors to enter into these arrangements.
  2. I warrant, on behalf of myself and my co-authors, that:
    • the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
    • I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
    • the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
    • I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
  3. I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
  4. I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.

Please visit Creative Commons web page for details of the terms.